Search Results - "Olesen, Majken L."

Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis by Pedersen, Rasmus S, Nissen, Neel I, Jensen, Christina, Thorlacius-Ussing, Jeppe, Manon-Jensen, Tina, Olesen, Majken L, Langholm, Lasse L, Diab, Hadi M H, Jorgensen, Lars N, Hansen, Carsten P, Chen, Inna M, Johansen, Julia S, Karsdal, Morten A, Willumsen, Nicholas

“…Pancreatic ductal adenocarcinoma (PDAC) is a hard-to-treat cancer due to the collagen-rich (fibrotic) and immune-suppressed microenvironment. A major driver of…”
Get full text

Harnessing human monoclonal antibodies for neutralisation of dendrotoxins in a murine model by Knudsen, Cecilie, Arias, Ana Silvia, Lomonte, Bruno, Mar a Guti rrez, Jos, Puš, rška, Oscoz, Saioa, Masters, Edward W., Luther, Alice M., Griffiths, Daniel.T., Olesen, Majken L., Leah, Rachael A, Slavny, Peter, Karatt-Vellatt, Aneesh, McCafferty, John, Laustsen, Andreas H.

Get full text

Harnessing phage display technology for generating fully human IgG antibodies that neutralise elapid neurotoxins by Karatt-Vellatt, Aneesh, Laustsen, Andreas H., Masters, Edward W., Oscoz, Saioa, Pus, Urska, Knudsen, Cecilie, Slavny, Peter, Luther, Alice M., Leah, Rachael A., Grifiths, Daniel T., Olesen, Majken L., Lomonte, Bruno, Gutiérrez, José María, McCafferty, John

Get full text

Abstract 1568: PLK activated TGF-β functions as a prognostic biomarker for patients with pancreatic ductal adenocarcinoma by Pedersen, Rasmus S., Nissen, Neel I., Jensen, Christina, Thorlacius-Ussing, Jeppe, Olesen, Majken L., Langholm, Lasse, Jensen, Tina M., Diab, Hadi M., Jørgensen, Lars N., Karsdal, Morten, Willumsen, Nicholas

“…Introduction: Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer death with a 5-year survival rate of approximately 7%…”
Get full text